141 related articles for article (PubMed ID: 37993039)
1. In vitro drug susceptibility using a parasite-rescue and transformation assay of Leishmania (Mundinia) martiniquensis and Leishmania (Mundinia) orientalis amastigotes against antileishmanial drugs.
Kimcharoensuk S; Leelayoova S; Mungthin M; Nawattanapaibool N; Tan-Ariya P; Siripattanapipong S
Acta Trop; 2024 Jan; 249():107081. PubMed ID: 37993039
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility to miltefosine of amphotericin B-resistant Leishmania (Mundinia) martiniquensis.
Mano C; Kongkaew A; Tippawangkosol P; Junkum A; Siriyasatien P; Jariyapan N
Parasitol Res; 2023 Dec; 122(12):3027-3035. PubMed ID: 37796293
[TBL] [Abstract][Full Text] [Related]
3. Anti-Leishmania activity of artesunate and combination effects with amphotericin B against Leishmania (Mundinia) martiniquensis in vitro.
Intakhan N; Siriyasatien P; Chanmol W
Acta Trop; 2022 Feb; 226():106260. PubMed ID: 34848183
[TBL] [Abstract][Full Text] [Related]
4. Determination of anti-leishmanial drugs efficacy against
Phumee A; Jariyapan N; Chusri S; Hortiwakul T; Mouri O; Gay F; Limpanasithikul W; Siriyasatien P
Parasite Epidemiol Control; 2020 May; 9():e00143. PubMed ID: 32300665
[TBL] [Abstract][Full Text] [Related]
5. Antileishmanial Activity and Synergistic Effects of Amphotericin B Deoxycholate with Allicin and Andrographolide against
Intakhan N; Chanmol W; Somboon P; Bates MD; Yardley V; Bates PA; Jariyapan N
Pathogens; 2020 Jan; 9(1):. PubMed ID: 31936536
[No Abstract] [Full Text] [Related]
6.
Chanmol W; Siriyasatien P; Intakhan N
PeerJ; 2022; 10():e12813. PubMed ID: 35111411
[No Abstract] [Full Text] [Related]
7. Leishmania (Mundinia) orientalis n. sp. (Trypanosomatidae), a parasite from Thailand responsible for localised cutaneous leishmaniasis.
Jariyapan N; Daroontum T; Jaiwong K; Chanmol W; Intakhan N; Sor-Suwan S; Siriyasatien P; Somboon P; Bates MD; Bates PA
Parasit Vectors; 2018 Jun; 11(1):351. PubMed ID: 29914526
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
9. Species diversity of phlebotomine sand flies and sympatric occurrence of Leishmania (Mundinia) martiniquensis, Leishmania (Leishmania) donovani complex, and Trypanosoma spp. in the visceral leishmaniasis focus of southern Thailand.
Preativatanyou K; Chinwirunsirisup K; Phumee A; Khositharattanakool P; Sunantaraporn S; Depaquit J; Siriyasatien P
Acta Trop; 2023 Aug; 244():106949. PubMed ID: 37211153
[TBL] [Abstract][Full Text] [Related]
10. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.
Jain SK; Sahu R; Walker LA; Tekwani BL
J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097
[TBL] [Abstract][Full Text] [Related]
11. Molecular identification of two newly identified human pathogens causing leishmaniasis using PCR-based methods on the 3' untranslated region of the heat shock protein 70 (type I) gene.
Jariyapan N; Bates MD; Bates PA
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009982. PubMed ID: 34847144
[TBL] [Abstract][Full Text] [Related]
12. In-Vitro Activity of Silybin and Related Flavonolignans against
Olías-Molero AI; Jiménez-Antón MD; Biedermann D; Corral MJ; Alunda JM
Molecules; 2018 Jun; 23(7):. PubMed ID: 29954145
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
Vermeersch M; da Luz RI; Toté K; Timmermans JP; Cos P; Maes L
Antimicrob Agents Chemother; 2009 Sep; 53(9):3855-9. PubMed ID: 19546361
[TBL] [Abstract][Full Text] [Related]
14. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
Reis TAR; Oliveira-da-Silva JA; Tavares GSV; Mendonça DVC; Freitas CS; Costa RR; Lage DP; Martins VT; Machado AS; Ramos FF; Silva AM; Ludolf F; Antinarelli LMR; Brito RCF; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Coimbra ES; Coelho EAF
Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468
[TBL] [Abstract][Full Text] [Related]
15. Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions.
Rugani JN; Quaresma PF; Gontijo CF; Soares RP; Monte-Neto RL
Biomed Pharmacother; 2018 Dec; 108():1170-1180. PubMed ID: 30372818
[TBL] [Abstract][Full Text] [Related]
16. Natural infection with
Kaewmee S; Mano C; Phanitchakun T; Ampol R; Yasanga T; Pattanawong U; Junkum A; Siriyasatien P; Bates PA; Jariyapan N
Front Microbiol; 2023; 14():1235254. PubMed ID: 37675418
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
18. In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes.
Kumar V; Kumari S; Ranjan R; Kumar A; Alti D
Exp Parasitol; 2024 Feb; 257():108688. PubMed ID: 38142765
[TBL] [Abstract][Full Text] [Related]
19. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes.
Kar N; Chakraborty S; De AK; Ghosh S; Bera T
Eur J Pharm Sci; 2017 Jun; 104():196-211. PubMed ID: 28400285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
